Organoids Market: Introduction
According to the report, the
global organoids
market was valued over US$ 1.7 Bn in 2019 and is projected to expand at a
high CAGR from 2020 to 2030. Organoids are replicated or miniaturized versions
of organs such as stomach, liver, lung, kidney, and brain produced from stems
cells in vitro. These miniature models are three-dimensional tissue culture
derived from stem cells. The stem cells are derived from pluripotent and organ
specific stem cells. The global organoids market is driven by rise in
prevalence of various diseases, sudden outbreak of infectious diseases in 2020,
and development of organoid models for studying various disease modeling, which
are expected to boost the organoids market during the forecast period.
Technological advancements leading to the development of organoids for
diagnosis and studying patient-derived tumors.
North America dominated the
global organoids market in 2019, followed by Europe and Asia Pacific. North
America’s dominance can be ascribed to technological advancements, development
& adoption of organoid models that resemble various organs, and high
clinical R&D expenditure by both governments and private players are likely
to drive the organoids market in North America during the forecast period.
Request Brochure of
Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=73363
Organoids as Therapeutic Tools to Drive Global Market
Organoids are considered
prominent tools for discovery of drugs, diagnosis, and development of treatment
for various chronic diseases. Rise in prevalence and increase in incidence of
various diseases drive scientists and researchers to continue research on
organoid models to study human physiology and disease modeling. Organoids are
considered innovative approach for drug discovery, disease modeling through
stem cell research, and innovating personalized medicines. These factors enable
faster adoption of organoids as therapeutic tools across the globe.
Amidst the COVID-19 pandemic,
researchers are using organoids as prominent tools to study the coronavirus
disease, modelling, and development of treatment. Organoids are considered
powerful tools for respiratory diseases or infections. These factors are
anticipated to propel the global organoids market.
Organoids Market: Prominent Regions
The global organoids market has
been segmented into North America, Europe, Asia Pacific, Latin America, and
Middle East & Africa. North America dominated the global organoids market
in 2019, followed by Europe and Asia Pacific. The presence of prominent players
conducting various studies using organoid models is a major factor boosting the
growth of the organoids market in North America. In April 2020, STEMCELL
Technologies, Inc. conducted projects in alliance with the University of
British Columbia (UBC) at Genome British Columbia for testing thousands of
FDA-approved drugs and clinical stage compounds alone or in combination for
drug repurposing against SARS-CoV-2 infection by using human organoid culture
technology.
Request for Analysis
of COVID-19 Impact on Organoids Market - https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_id=73363
The organoids market in Europe is
anticipated to expand at a high CAGR from 2020 to 2030. The presence of key
players offering organoids, technological advancements, large patient pool,
increase in the geriatric population, and rise in prevalence of chronic
diseases are anticipated to boost the growth of the organoids market in the
region. Moreover, the company offers innovative portfolio of organoid models
for drug screening, development of regenerative medicine, personalized
medicine, and other therapeutic application. This is expected to fuel the
growth of the organoids market in Europe during the forecast period.
Investments toward Development of Innovative Organoid Product Offerings
and Geographic Presence of Key Players to Drive Global Market
The global organoids market is
consolidated in terms of number of players. The market is dominated by key
players with innovative product offerings, robust geographic presence, and
large investments in research & development. Leading players operating in
the global organoids market include STEMCELL Technologies Inc., Cellesce Ltd.,
Hubrecht Organoid Technology, Definigen, 3Dnamics, Inc., Organoid Therapeutics,
PeproTech, Inc., Thermo Fisher Scientific, Corning Incorporated (Life
Sciences), and Merck KGgA. Prominent players have introduced innovative
organoid models amidst the COVID-19 pandemic to study the disease pathology and
develop innovative treatment. Moreover, companies are investing in continuous
research & development for wide therapeutic applications.
Pre Book Organoids
Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_id=73363<ype=S
In February 2020, Cellesce Ltd.
published application of patient-derived organoids in the early cancer drug
discovery, which would offer significant benefits to cancer patients. The
company invests in continuous research and development for identifying tumor
derived organoid as a novel solution for the drug discovery and its benefits in
the cancer research.
More Trending Reports
by Transparency Market Research –
Cardiovascular
Monitoring and Diagnostic Devices Market: https://www.biospace.com/article/cardiovascular-monitoring-and-diagnostic-devices-market-ecg-systems-to-remain-leading-product-segment-until-2024/
Read our Case study
at https://www.transparencymarketresearch.com/casestudies/innovative-medical-device-manufacturing-start-up
About Us
Transparency Market Research is a
global market intelligence company providing global business information
reports and services. Our exclusive blend of quantitative forecasting and
trends analysis provides forward-looking insight for several decision makers.
Our experienced team of analysts, researchers, and consultants use proprietary
data sources and various tools and techniques to gather and analyze
information.
Our data repository is
continuously updated and revised by a team of research experts so that it
always reflects latest trends and information. With a broad research and
analysis capability, Transparency Market Research employs rigorous primary and
secondary research techniques in developing distinctive data sets and research
material for business reports.
Contact
Transparency Market Research,
90 Sate Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free:
866-552-3453
